All In Biotech

Drug Trial Radar · NCT03525613

A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

A Phase 3, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal Pegcetacoplan Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Last checked: Nov 19, 2026Latest source record: Jul 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 637 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

637

Actual

Start

Aug 31, 2018

Primary completion

Jun 28, 2021

Study completion Jun 28, 2022

Sponsor

Lead sponsor
Apellis Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
May 15, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a 24-month, Phase III, multicenter, randomized, double-masked, sham-injection controlled study to assess the efficacy and safety of multiple IVT injections of APL-2 in subjects with GA secondary to AMD.

Conditions

  • Geographic Atrophy

Interventions

  • APL-2Drug

    Complement (C3) Inhibitor

  • APL-2Drug

    Complement (C3) Inhibitor

  • Sham ProcedureOther

    Subjects will receive a Sham procedure every month

  • Sham ProcedureOther

    Subjects will receive a Sham procedure every other month

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Least Squares (LS) Mean Change From Baseline in Total Area of GA Lesions in the Study Eye at Month 12Time frame: Baseline (screening) and Month 12

Locations

112 sites in 14 countries. Site status is shown where the registry gives one.

  • Arizona Retina & Vitreous Consultants

    Phoenix, Arizona

  • California Retina Consultants

    Bakersfield, California

  • Retina Vitreous Associates Medical Group

    Beverly Hills, California

  • Retinal Diagnostic Center

    Campbell, California

  • Retina Consultants of Orange County

    Fullerton, California

  • Atlantis Eyecare

    Huntington Beach, California

  • University of California, San Diego, Jacobs Retina

    La Jolla, California

  • Byers Eye Institute at Stanford, Stanford School of Medicine

    Palo Alto, California

  • Doheny Eye Center UCLA

    Pasadena, California

  • Retina Consultants San Diego

    Poway, California

  • Retinal Consultants Med Group, Inc.

    Sacramento, California

  • Orange County Retina Medical Group

    Santa Ana, California

  • California Retina Consultants

    Santa Barbara, California

  • Southwest Retina Research Center, LLC

    Durango, Colorado

  • Colorado Retina Associates

    Golden, Colorado

  • Retina Group of New England

    Waterford, Connecticut

  • Blue Ocean Clinical Research / The Macula Center

    Clearwater, Florida

  • National Ophthalmic Research Institute (Retina Consultants of Southwest Florida)

    Fort Myers, Florida

  • Bascom Palmer Eye Institute

    Miami, Florida

  • Bascom Palmer Eye Institute of Naples

    Naples, Florida

  • Retina Specialty Institute

    Pensacola, Florida

  • Center for Retina and Macular Disease

    Winter Haven, Florida

  • Southeast Retina Center, PC

    Augusta, Georgia

  • Gailey Eye Clinic Retina Center

    Bloomington, Illinois

  • Northwestern Feinberg School of Medicine

    Chicago, Illinois

  • Rush University Medical Center

    Chicago, Illinois

  • Midwest Eye Institute

    Indianapolis, Indiana

  • Retina and Vitreous Associates of Kentucky, PSC dba Retina Associates of Kentucky

    Lexington, Kentucky

  • Retina Associates New Orleans

    Metairie, Louisiana

  • The Retina Care Center

    Baltimore, Maryland

  • The Retina Group of Washington

    Chevy Chase, Maryland

  • Cumberland Valley Retina Center

    Hagerstown, Maryland

  • Mid Atlantic Retina Specialists

    Hagerstown, Maryland

  • Tufts Medical Center

    Boston, Massachusetts

  • New England Retina Consultants

    Springfield, Massachusetts

  • Michigan Medicine Kellogg Eye Center

    Ann Arbor, Michigan

  • Associated Retinal Consultants, P.C

    Grand Rapids, Michigan

  • VitreoRetinal Surgery PA

    Minneapolis, Minnesota

  • Sierra Eye Associates

    Reno, Nevada

  • Retina Center of NJ, LLC

    Bloomfield, New Jersey

Showing 40 of 112 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.